companydata.dkcompanydata.dk

PHARMAVIE A/S: Financial statements 2022

CVR: 26553148

Source: annual report 2022, Danish Business Authority

01/01/2022 – 31/12/2022

PHARMAVIE A/S (CVR 26553148) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 330,758 and a net result of DKK -1,077,009 compared with DKK 1,355,296 the year before. That is an increase of 34.4% compared with the year before. Equity in the 2022 report amounted to DKK 990,489. The solvency ratio was 6.7%. The company had 1 employee in the financial year.

Gross Profit
DKK 330,758
Profit/Loss
DKK -1,077,009
Equity
DKK 990,489
Total Assets
DKK 14,866,072
Employees
1

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2022-331K-1.1M990K1
2021-246K1.4M2.1M-
2020--173K6K712K1
2019--241K-1.3M706K1
2018--240K564K2M-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Keep an eye on PHARMAVIE A/S

Get notified instantly about new financial statements, ownership changes, management changes and status changes.

Set up monitoring

Events in 2022

PHARMAVIE A/S: The 2021 annual report is outFeb 23, 2022

PHARMAVIE A/S has published its annual report for 2021. Gross profit came to DKK 246,057, and the net result was DKK 1,355,296.

About PHARMAVIE A/S

PHARMAVIE A/S is a Danish company of the type Aktieselskab based in Greve, founded in 2002. The company is registered under the industry Virksomhedsrådgivning og anden ledelsesrådgivning. The company was previously named PHARMAVIE CONSULT A/S. The management consists of Carsten Wærn. The board consists of Margit Wærn (chair), Carsten Wærn and Vibeke Wærn. The company is owned by MAW HOLDING ApS and VIPS HOLDING ApS. The company has 1 employee (2025). In 2025, the company reported a gross profit of DKK 172,767 and a net result of DKK 821,439 compared with DKK 1,603,686 the year before. Equity in the 2025 report amounted to DKK -978,681.

Source: annual report 2025, Danish Business Authority